İçeriğe geç

Onkoloji (Çocuk)

Uygun Hemostaz (Kanamanın Durması)

Antifibrinolitik İlaçlar

Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. (yeni pencere açar)

Antun AG, Gleason S, Arellano M, Langston AA, McLemore ML, Gaddh M, el Rassi F, Bernal-Mizrachi L, Galipeau J, Heffner LT Jr, Winton EF, Khoury HJ.

Kaynak‎: Cancer 2013;119(21):3784-7.

İndeks‎: PubMed 23921838

DOI‎: 10.1002/cncr.28253

https://www.ncbi.nlm.nih.gov/pubmed/23921838 (yeni pencere açar)

Low dose bolus aminocaproic acid: an alternative to platelet transfusion in thrombocytopenia? (yeni pencere açar)

Chakrabarti S, Varma S, Singh S, Kumari S

Kaynak‎: Eur J Haematol 1998;60(5):313-4.

İndeks‎: PubMed 9654162

DOI‎: 10.1111/j.1600-0609.1998.tb01046.x

https://www.ncbi.nlm.nih.gov/pubmed/9654162 (yeni pencere açar)

The use of antifibrinolytics in pediatric patients with hypoproliferative thrombocytopenia. (yeni pencere açar)

Delaney M, Matthews DC, Gernsheimer TB

Kaynak‎: Pediatr Blood Cancer 2017;64(12):e26641.

İndeks‎: PubMed 28544698

DOI‎: 10.1002/pbc.26641

https://www.ncbi.nlm.nih.gov/pubmed/28544698 (yeni pencere açar)

A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. (yeni pencere açar)

Shpilberg O, Blumenthal R, Sofer O, Katz Y, Chetrit A, Ramot B, Eldor A, Ben-Bassat I.

Kaynak‎: Leuk Lymphoma 1995;19(1-2):141-4.

İndeks‎: PubMed 8574160

DOI‎: 10.3109/10428199509059668

https://www.ncbi.nlm.nih.gov/pubmed/8574160 (yeni pencere açar)

Rekombinant Aktive Faktör VII (rFVIIa)

Pediatric off-label use of recombinant factor VIIa. (yeni pencere açar)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

Kaynak‎: Pediatrics 2009;123(3):1066-72.

İndeks‎: PubMed 19255041

DOI‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (yeni pencere açar)

Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience. (yeni pencere açar)

Bhat S, Yadav SP, Anjan M, Dinand V, Sachdeva A.

Kaynak‎: Indian J Pediatr 2011;78(8):961-8.

İndeks‎: PubMed 21328080

DOI‎: 10.1007/s12098-011-0364-6

https://www.ncbi.nlm.nih.gov/pubmed/21328080 (yeni pencere açar)

Safety and efficacy of recombinant factor VIIa by pediatric age cohort: reassessment of compassionate use and trial data supporting US label. (yeni pencere açar)

Croteau SE, Nakar C, Neufeld EJ, Shapiro A, Cooper DL

Kaynak‎: Pediatr Blood Cancer 2016;63(10):1822-8.

İndeks‎: PubMed 27232114

DOI‎: 10.1002/pbc.26082

https://www.ncbi.nlm.nih.gov/pubmed/27232114 (yeni pencere açar)

Use of recombinant factor VIIa prior to lumbar puncture in pediatric patients with acute leukemia. (yeni pencere açar)

Das P, Carcao M, Hitzler J

Kaynak‎: Pediatr Blood Cancer 2006;47(2):206-9.

İndeks‎: PubMed 16007583

DOI‎: 10.1002/pbc.20467

https://www.ncbi.nlm.nih.gov/pubmed/16007583 (yeni pencere açar)

A comprehensive review of rFVIIa use in a tertiary care pediatric center. (yeni pencere açar)

Heller M, Lau W, Pazmino-Canizares J, Brandão LR, Carcao M

Kaynak‎: Pediatr Blood Cancer 2008;50(5):1013-7.

İndeks‎: PubMed 17960639

DOI‎: 10.1002/pbc.21375

https://www.ncbi.nlm.nih.gov/pubmed/17960639 (yeni pencere açar)

Recombinant activated factor VII for severe gastrointestinal bleeding after chemotherapy in an infant with acute megakaryoblastic leukemia. (yeni pencere açar)

Kurekci AE, Atay AA, Okutan V, Yavuz ST, Ozcan O

Kaynak‎: Blood Coagul Fibrinolysis 2005;16(2):145-7.

İndeks‎: PubMed 15741803

DOI‎: 10.1097/01.mbc.0000161569.66764.70

https://www.ncbi.nlm.nih.gov/pubmed/15741803 (yeni pencere açar)

Off-label use of recombinant factor VIIa in pediatric patients. (yeni pencere açar)

McQuilten ZK, Barnes C, Zatta A, Phillips LE; Haemostasis Registry Steering Committee

Kaynak‎: Pediatrics 2012;129(6):e1533-40.

İndeks‎: PubMed 22641758

DOI‎: 10.1542/peds.2011-2561

https://www.ncbi.nlm.nih.gov/pubmed/22641758 (yeni pencere açar)

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (yeni pencere açar)

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

Kaynak‎: Pediatr Hematol Oncol 2008;25(4):301-11.

İndeks‎: PubMed 18484474

DOI‎: 10.1080/08880010802016904

https://www.ncbi.nlm.nih.gov/pubmed/18484474 (yeni pencere açar)

Desmopresin

The use of DDAVP in children with bleeding disorders. (yeni pencere açar)

Ben-Ami T, Revel-Vilk S

Kaynak‎: Pediatr Blood Cancer 2013;60 Suppl 1:S41-3.

İndeks‎: PubMed 23109357

DOI‎: 10.1002/pbc.24335

https://www.ncbi.nlm.nih.gov/pubmed/23109357 (yeni pencere açar)

Topikal Hemostatik (Kanama Durdurucu) İlaçlar

The use of Tachosil as hemostatic sealant in nephron sparing surgery for Wilms tumor: preliminary observations. (yeni pencere açar)

Mele E, Ceccanti S, Schiavetti A, Bosco S, Masselli G, Cozzi DA

Kaynak‎: J Pediatr Surg 2013;48(3):689-94.

İndeks‎: PubMed 23480936

DOI‎: 10.1016/j.jpedsurg.2013.01.019

https://www.ncbi.nlm.nih.gov/pubmed/23480936 (yeni pencere açar)